Last reviewed · How we verify
NCT01190722
A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
Phase 4 trial testing etoricoxib in Hallux Valgus. Withdrawn.
11 December 2010
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Start date | 10 November 2010 |
| Primary completion | 11 December 2010 |
| Estimated completion | 12 December 2010 |
Drugs / interventions tested
- etoricoxib (ETORICOXIB) — full drug profile →
- Diclofenac (DICLOFENAC) — full drug profile →
Conditions studied
- Hallux Valgus — all drugs for Hallux Valgus →
- Postoperative Pain — all drugs for Postoperative Pain →
Sponsor
Karolinska Institutet
Who can join
Adults 18 to 65, any sex, with Hallux Valgus or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01190722
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of etoricoxib
Trials testing the same drug.
- NCT01327638 — Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013 · completed
Other recruiting trials for Hallux Valgus
Currently open trials in the same condition.
- NCT07267156 — Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery · NA · recruiting
- NCT07378917 — Orthotic Impact on MTP Alignment in Hallux Valgus · NA · recruiting
- NCT06185608 — The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks · NA · recruiting
- NCT06874517 — Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot · recruiting
- NCT06541119 — Effect of Selective Strengthening of Peroneus Longus on Pain , Joint Alignment and Foot Function in Hallux Valgus · NA · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01190722 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 2 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01190722.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing